Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Certara expands into QSP field
February 2016
EDIT CONNECT

SHARING OPTIONS:

PRINCETON, N.J.—Certara, a global biosimulation technology-enabled drug development company, recently announced the acquisition of XenologiQ, a U.K.-based quantitative systems pharmacology (QSP) consultancy, in a move Certara CEO Dr. Edmundo Muniz said “strengthens Certara’s modeling and simulation capabilities, increases its leadership in mechanistic pharmacology and supports the company’s precision medicine vision.” Though no financial details were disclosed, it was announced that the XenologiQ team will join Certara’s Simcyp division in the wake of the transaction, with the XenologiQ directors taking up leadership positions in the Simcyp QSP organization. QSP combines computational modeling and experimental methods to examine the mechanistic relationships between a drug, the biological system and the disease process, integrating quantitative drug data with knowledge of a drug’s mechanism of action.
 
Code:

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.